# Equivalence Study of Dorzolamide 2% Eye Drops Solution

> **NCT00878917** · PHASE3 · COMPLETED · sponsor: **Alfred E. Tiefenbacher (GmbH & Co. KG)** · enrollment: 32 (actual)

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Dorzolamide 2 % eye drops solution

## Key facts

- **NCT ID:** NCT00878917
- **Lead sponsor:** Alfred E. Tiefenbacher (GmbH & Co. KG)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2010-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00878917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00878917, "Equivalence Study of Dorzolamide 2% Eye Drops Solution". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00878917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*